US FDA blocks some flavors of British American Tobacco's key vape brand Vuse
Reuters
Published Oct 12, 2023 12:55PM ET
Updated Oct 12, 2023 02:36PM ET
(Reuters) -The U.S. health regulator on Thursday blocked the sale of six flavors of British American Tobacco (NYSE:BTI)'s (BAT (LON:BATS)) main vape brand, Vuse Alto, in the market including the menthol flavor that makes up a large portion of its sales.
The U.S. Food and Drug Administration's (FDA) marketing denial orders (MDOs) for R.J. Reynolds, owned by BAT, include three menthol-flavored and three mixed berry-flavored e-cigarette products, with each flavor being offered in three nicotine strengths.
"R.J. Reynolds Vapor company intends to challenge denials and will seek a stay of enforcement of menthol denial immediately," BAT said.
The FDA said evidence submitted by R.J. Reynolds failed to prove that menthol- and mixed berry-flavored products offered an added benefit for adult cigarette smokers compared to tobacco-flavored products that is sufficient to outweigh the known risks to youth.
But the company may submit new applications for the products that are subject to these MDOs, it said.
In the past, companies have challenged FDA decisions in court, with some success.
A subsidiary of rival Imperial Brands (OTC:IMBBY) had disputed the FDA's decision to ban its flavored and unflavored vape products. A U.S. appeals court in August agreed that its unflavored products should be reviewed again by the FDA.
Vuse Alto makes up the vast majority of BAT's vape volumes in the United States, with menthol flavors accounting for around 75% of that, according to Jefferies.
Jefferies analyst Owen Bennett noted that BAT may succeed in securing a stay, which could prevent the product being removed from the market.
A rise in disposable vapes has dented BAT's business in the world's largest market for such products. Its U.S. vape volumes were down 6.5% in the first half of 2023.
BAT bought out R.J. Reynolds for $49.4 billion in 2017, gaining access to the lucrative and highly regulated U.S. market after a long absence since 2004.
Get The News You Want
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.